New eye drop aims to beat artificial tears for dry eye relief
NCT ID NCT07078955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new eye drop called BRM421 against standard artificial tears in 99 adults with dry eye disease. The goal is to see if BRM421 is safe and better at reducing eye damage and discomfort. Participants will use the drops for 6 weeks, and doctors will measure changes in the eye surface and symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Taipei Municipal TuCheng Hospital
New Taipei City, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New eye drop aims to soothe dryness after cataract surgery
- Can simple eye drops soothe dry eyes? new study puts OTC brands to the test
- New eye drops aim to soothe dry eye sufferers